Medical Foods Market Size Worth $30.34 Billion By 2028 | CAGR: 5.2%: Grand View Research, Inc.

SAN FRANCISCO, Feb. 3, 2021 /PRNewswire/ -- The global medical foods market size is anticipated to reach USD 30.34 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. Factors such as the growing prevalence of chronic conditions along with the increasing geriatric population adopting medical foods are positively impacting the growth. Rising awareness regarding clinical nutrition among healthcare professionals and patients is projected to further bolster the growth over the forecast period.

Based on the route of administration, oral administration dominated the market in 2020. Factors contributing to the high share include high commercial viability of orally administered products and high preference for orally administered medical foods owing to ease in consumption. Oral supplements are available in various forms such as powders, pills, puddings, and pre-thickened products, thereby propelling the overall growth.

Key suggestions from the report:

• The oral segment accounted for the highest revenue share in 2020, owing to the high commercial viability of orally administered products and high preference for orally administered medical foods
• The others' segment dominated the market in 2020, owing to increasing application areas, high commercial availability, and easy administration of the products
• Diabetic Neuropathy dominated the market in 2020, owing to increasing diabetes prevalence and the rising number of patients that are at risk of developing some level of neuropathy
• Institutional sales accounted for the highest revenue share in 2020, owing to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers
• North America dominated the market with a revenue share of 29.9% in 2020, owing to the presence of key market players and high revenue generated by these players in this region.

Read 118 page research report with ToC on "Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration, By Product (Pills, Powder), By Application, By Sales Channel, By Region, And Segment Forecasts, 2021 - 2028" at: https://www.grandviewresearch.com/industry-analysis/medical-foods-market

In 2020, based on product type, the others segment accounted for the highest revenue share. The others' segment comprises of liquid, semi-liquid, and semi-solid products. This growth is attributed to increasing application areas of medical foods, high commercial availability, and easy administration of these products. Owing to ease of consumption, liquid formulations are preferred by geriatric as well as pediatric populations, thereby increasing its overall revenue share.

Based on application, diabetic neuropathy dominated the market share in 2020. Rising diabetes prevalence and an increase in the number of patients that are at risk of developing some level of neuropathy are some of the factors boosting the overall growth. For instance, according to Healthline, around 60% to 70% of people suffering from diabetes have some or other form of neuropathy. The risk of suffering from neuropathy increases with an aging, unhealthy lifestyle, and change in diet which leads to an increased focus on nutritional management, thereby fueling the growth.

In 2020, based on sales channels, institutional sales accounted for the highest revenue share. This share is attributable to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers. There is an increase in demand for such products in inpatient facilities. Hence, rising demand and consumption of these products under medical supervision are some of the factors contributing to the growth of the segment.

North America dominated the market with a revenue share of 29.9% in 2020 owing to the presence of key market players and high revenue generated by these players in this region. Strategic initiatives by players, increasing prevalence of chronic conditions, and rising adoption of medical foods by healthcare professionals and patients are other factors supporting the regional market growth.

Grand View Research has segmented the global medical foods market based on the route of administration, product, application, sales channel, and region:

• Medical Foods Route of Administration Outlook (Revenue, USD Million, 2014 - 2028)
• Oral
• Enteral
• Medical Foods Product Outlook (Revenue, USD Million, 2014 - 2028)
• Pills
• Powder
• Others
• Medical Foods Application Outlook (Revenue, USD Million, 2014 - 2028)
• Chronic Kidney Disease
• Minimal Hepatic Encephalopathy
• Chemotherapy-induced Diarrhea
• Pathogen Related Infections
• Diabetic Neuropathy
• ADHD
• Depression
• Alzheimer's Disease
• Nutritional Deficiency
• Orphan Diseases
• Phenylketonuria
• Eosinophilic Esophagitis
• FPIES
• Others
• Other
• Medical Foods Sales Channel Outlook (Revenue, USD Million, 2014 - 2028)
• Online Sales
• Retail Sales
• Institutional Sales
• Medical Foods Regional Outlook (Revenue, USD Million, 2014 - 2028)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Asia-Pacific
• Australia
• China
• Japan
• South Korea
• India
• New Zealand
• Singapore
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East Africa
• South Africa
• Saudi Arabia
• UAE

List of Key Players of Medical Foods Market

• Danone
• Nestle Nutrition
• Abbott Nutrition
• Targeted Medical Pharma, Inc.
• Primus Pharmaceuticals, Inc.
• Mead Johnson & Company, LLC.
• Medtrition, Inc.
• Fresenius Kabi AG.

Find more research reports on Pharmaceuticals Industry, by Grand View Research:

• Attention Deficit Hyperactivity Disorder Market – The global attention deficit hyperactivity disorder market size was valued at USD 16.4 billion in 2018 and is estimated to exhibit a CAGR of 6.4% over the forecast period.
• Diabetic Food Market – The global diabetic food market size was valued at USD 7.0 billion in 2015 and is expected to witness significant growth over the forecast period. Growing awareness over diabetes coupled with preventive measures taken by consumers is anticipated to spur the market growth.
• Enteral Feeding Formulas Market – The global enteral feeding formulas market size was valued at USD 5.46 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% from 2020 to 2027.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg